In vitro diagnostic kit for the simultaneous detection of the G20210A mutation in the prothrombin gene (FII) and the G1691A mutation in Factor V using real-time PCR.
Detailed description
Operating principle
The assay is based on the real-time PCR (Real-Time PCR) amplification of specific regions of the FII and FV factor genes containing the mutations of interest. It uses TaqMan® hydrolysis probes labelled with fluorophores (FAM, HEX, ROX and Cy5) that enable allelic discrimination. The fluorescent signal generated during amplification is proportional to the amplified DNA and enables genotype determination.
Clinical applications
Qualitative detection of the G20210A (FII) and G1691A (Factor V Leiden) mutations, associated with the risk of venous thrombosis and inherited thrombophilia.
Key aspects and benefits
Key indicators
Intended users
Technical personnel trained and qualified in molecular biology and genetic analysis in specialised clinical laboratories.









